Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

Area of Science:

• Biochemistry
• Immunology
• Ophthalmology

Background:

• Oxidative stress and lipid peroxidation contribute to chronic inflammatory diseases like age-related macular degeneration (AMD).
• Malondialdehyde (MDA) is a key lipid peroxidation product accumulating in AMD pathogenesis.
• The exact causes of AMD, a leading cause of blindness, are not fully understood.

Purpose of the Study:

• To identify proteins that bind malondialdehyde (MDA).
• To investigate the role of MDA binding in innate immune responses and AMD.
• To explore the functional impact of the CFH H402 polymorphism on MDA binding.

Main Methods:

• Protein-ligand binding assays to identify MDA-binding proteins.
• Macrophage uptake assays for MDA-modified proteins.
• In vivo mouse models to assess MDA-induced inflammation.
• Genotyping and functional assays for complement factor H (CFH) variants.

Main Results:

• Complement factor H (CFH) was identified as a major protein that binds MDA.
• CFH binding to MDA inhibits macrophage uptake of MDA-modified proteins and reduces MDA-induced inflammation in mice.
• The AMD-associated CFH H402 polymorphism significantly impairs CFH's ability to bind MDA.

Conclusions:

• CFH plays a crucial role in mitigating the effects of oxidative stress by binding MDA.
• The reduced MDA-binding capacity of the CFH H402 variant provides a mechanistic link to AMD aetiology.
• Targeting the CFH-MDA interaction may offer novel therapeutic strategies for AMD and other inflammatory conditions.